Biotechnology News

August 16, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB): Second quarter 2012 · Net sales amounted to MSEK 21.9 (24.0). · Operating profit totalled MSEK 2.2 (6.3). · Profit after tax amounted to MSEK 2.0 (4.9). · Profit after tax per...

August 16, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350,...

August 15, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization urges consideration of the impact on advanced biofuel producers that will occur from a waiver of the Renewable Fuel Standard

August 15, 2012

INDIANAPOLIS & ADELAIDE, Australia--(BUSINESS WIRE)--Dow AgroSciences and the Australian Centre for Plant Functional Genomics have entered into a crop improvement research, option, and license agreement.

August 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has priced its previously announced offering of senior notes: $500 million aggregate principal amount of 1....

August 15, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ: FLDM) today announced that it intends to offer shares of its common stock in an underwritten public offering.

August 15, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced the results of voting at its 2012 Annual Meeting of Stockholders (the Annual Meeting) held August 14, 2012.

August 15, 2012

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Konky Sotomayor, DVM, developer of the Salmogenics Vaccine, was appointed Chief Scientist of Global Green, Inc.

August 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A newly published benchmarking study found that pharmaceutical companies spend upwards of $30 million on their global medical science liaison (MSL) operations.

August 15, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB:CORX) reported a net loss of approximately $995,000, or $0.01 per share, for the quarter ended June 30, 2012, compared with a net loss of approximately $356,000, or $0.00 per...

August 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it intends to offer senior notes to fund its acquisition of One Lambda and for other general corporate purposes...

August 15, 2012

MT. OLIVE, N.J.--(BUSINESS WIRE)--Specialty pharmacy takes center stage when leading experts in the pharmaceutical and biotech manufacturers' industries gather in Las Vegas, September 19-21 to discuss the current changes and trends developing in...

August 15, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended June 30, 2012. Kinneret Savitsky, Ph.D., CEO of BioLineRx, remarked, “During the...

August 15, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa Inc announced an $80M Series C preferred stock financing to fund late-stage development, submission of an NDA and commercial planning for patiromer (RLY5016), a high capacity potassium binder.

August 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, has been granted a United States Patent for a bio-based adipic acid...

August 15, 2012

SAN FRANCISCO--(BUSINESS WIRE)--The Thiel Foundation announced today three new grants awarded through Breakout Labs. The newest awards focus on solutions at the intersection of biology and advanced technologies.

August 15, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka America Pharmaceutical, Inc. today announced the launch of patient management programs for Sprycel® (dasatinib) patients with a select group of specialty...

August 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell immune...

August 15, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and...

August 15, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) (“ImmunoCellular” or the “Company”), today announced second quarter results for the period ended June 30, 2012. Highlights of the second quarter and recent weeks...

August 15, 2012

SAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. (“Epic”), a privately held cancer diagnostics company, announced today that it has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“...

August 15, 2012

BANGKOK--(BUSINESS WIRE)--Vejthani Hospital offers Sprained Ankle Treatment, the way to relieve your pain at Vejthani Orthopaedic Clinic in Bangkok Thailand.

August 14, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its second...

August 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--HEI, Inc. (Pink Sheets: HEII; http://www.heii.com) today announced its financial results for the second quarter of fiscal year 2012, which ended June 30,...

August 14, 2012

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. today reported its operating results for the three and six months ended June 30, 2012. Vasomedical Announces 48.7% Increase in Revenue for the Second Quarter 2012.

August 14, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology released its financial results for the second quarter of 2012 and provided an update on the development program for its lead drug candidate, neratinib.

August 14, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics Reports Second Quarter 2012 Financial Results

August 14, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for the three and six months ended June 30, 2012. Full financial statements and...

August 14, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen Reports Record 2Q12 revenues

August 14, 2012

WASHINGTON & MUMBAI, India--(BUSINESS WIRE)--Recognizing India as a model for the global vaccine market, BIO is pleased to announce programming to highlight this achievement at the 3rd Annual BIO India International Conference, September 12-...

August 14, 2012

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Altura Medical, Inc., an early stage medical device manufacturer, announced the appointment of G. Ray Martin, Ph.D. as Altura’s President and Chief Executive Officer and a member of the Board of Directors....

August 14, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--BioHorizons, a leading dental implant company, releases MinerOss Cancellous for dental bone grafting, expanding BioHorizons’ comprehensive offering of bone and soft tissue grafting products.

August 14, 2012

MOUNTAINSIDE, N.J.--(BUSINESS WIRE)--Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that the U.S. Food and Drug Administration...

August 14, 2012

NEW YORK--(BUSINESS WIRE)--FertilityAuthority, the world's largest web portal for fertility information, has launched a new online patient scheduling service.

August 14, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that 77 percent of surveyed neurologists have experience with the STRATIFY JCVTM assay...

August 14, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health today announced the acquisition of PharmaDeals Ltd., a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global...

August 14, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own...

August 14, 2012

MAPLE GROVE, Minn.--(BUSINESS WIRE)--UPSHER-SMITH COMPLETES ACQUISITION OF PROXIMAGEN GROUP PLC

August 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, today announced that Robert Parson has joined the company’s management team as the Vice President of Regulatory and Clinical Affairs. Robert has 35 years of...

August 14, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for disposable anesthesia products

August 14, 2012

IRVINE, Calif. & LOUISVILLE, Colo.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB:CORX) and Pier Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced they have consummated a merger under which Cortex and Pier...

August 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc. has received exclusive license from Stanford University to immune repertoire capture technology that will accelerate discovery, development of novel therapeutic antibodies and vaccines.

August 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics announced that company scientists, founders and co-founders made several presentations at scientific conferences in the last month highlighting the company's recent progress.

August 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Top 10 drug makers have already invested significant manpower into digital marketing groups, averaging more than 23 FTEs dedicated to these new media activities, according to a new study.

August 14, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ:PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has finalized a reverse stock split. As previously announced in a news release dated...

August 14, 2012

PETALUMA, Calif.--(BUSINESS WIRE)--Tegal Corporation (NASDAQ: TGAL) today announced financial results for the First Quarter Fiscal Year 2013, which ended June 30, 2012. Fiscal 2013 First Quarter Financial Statement Highlights The Company’s Net...

August 14, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--McKesson Health Solutions announced that IDC Health Insights named it a “major player” in care management.

August 14, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--National Disability Institute (NDI) and Acorda Therapeutics announced they will launch a free six-part webinar series on financial, tax and investment topics for people living with multiple sclerosis (MS), their...

August 14, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, in partnership with the open-access publisher PLOS and open data repository figshare, announced today the launch of the Reproducibility Initiative (...